Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 4Stomach Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Psychological Well-Being 1Ovarian Neoplasms 1Muscle Invasive Bladder Cancer (MIBC) 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Malnutrition 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Inflammation 1Helicobacter Infections 1Esophageal Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Breast Carcinoma In Situ 1

Interventions

trilaciclib 1durvalumab 1Sodium Chloride 1Probiotics 1Immunotherapy 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Limited Stage Small Cell Lung Cancer × Probiotics × 1 year × Clear all
NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Fudan University

Phase 2 Recruiting
60 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡